| 2024年中报 | 2023年年报 | 2023年中报 | 2022年年报 | 2022年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 传染病检测(元) | 481,064,872.57 | 951,608,292.69 | 427,612,466.40 | 3,936,326,536.44 | 3,207,484,139.90 |
| 慢性疾病检测(元) | 761,928,173.27 | 1,118,523,310.41 | 717,820,258.14 | 939,070,842.49 | 511,645,762.72 |
| 毒品(滥用药物)检测(元) | - | 330,740,691.47 | 163,593,384.09 | 293,516,536.84 | - |
| 妊娠及优生优育检测(元) | - | 266,923,996.95 | - | 242,472,774.90 | - |
| 其他类(元) | - | 97,117,865.88 | - | 262,233,523.28 | - |
| 营业成本(元) | |||||
| 传染病检测(元) | 193,633,396.15 | 402,076,175.80 | 175,667,818.15 | 1,955,290,491.66 | 1,392,402,777.26 |
| 慢性疾病检测(元) | 191,515,944.48 | 276,156,377.53 | 190,571,335.48 | 328,531,427.38 | 178,111,843.99 |
| 毒品(滥用药物)检测(元) | - | 141,537,450.94 | 69,733,584.44 | 144,798,081.08 | - |
| 妊娠及优生优育检测(元) | - | - | - | 137,885,572.73 | - |
| 其他类(元) | - | - | - | 165,161,758.89 | - |
| 毛利(元) | |||||
| 传染病检测(元) | 287,431,476.42 | 549,532,116.89 | 251,944,648.25 | 1,981,036,044.78 | 1,815,081,362.64 |
| 慢性疾病检测(元) | 570,412,228.79 | 842,366,932.88 | 527,248,922.66 | 610,539,415.11 | 333,533,918.73 |
| 毒品(滥用药物)检测(元) | - | 189,203,240.53 | 93,859,799.65 | 148,718,455.76 | - |
| 妊娠及优生优育检测(元) | - | - | - | 104,587,202.17 | - |
| 其他类(元) | - | - | - | 97,071,764.39 | - |
| 毛利率(%) | |||||
| 传染病检测(%) | 59.75 | 57.75 | 58.92 | 50.33 | 56.59 |
| 慢性疾病检测(%) | 74.86 | 75.31 | 73.45 | 65.02 | 65.19 |
| 毒品(滥用药物)检测(%) | - | 57.21 | 57.37 | 50.67 | - |
| 妊娠及优生优育检测(%) | - | - | - | 43.13 | - |
| 其他类(%) | - | - | - | 37.02 | - |
| 收入构成(%) | |||||
| 传染病检测(%) | 38.70 | 34.42 | 32.67 | 69.38 | 86.24 |
| 慢性疾病检测(%) | 61.30 | 40.45 | 54.84 | 16.55 | 13.76 |
| 毒品(滥用药物)检测(%) | - | 11.96 | 12.50 | 5.17 | - |
| 妊娠及优生优育检测(%) | - | 9.65 | - | 4.27 | - |
| 其他类(%) | - | 3.51 | - | 4.62 | - |
| 毛利构成(%) | |||||
| 传染病检测(%) | 33.51 | 34.76 | 28.86 | 67.34 | 84.48 |
| 慢性疾病检测(%) | 66.49 | 53.28 | 60.39 | 20.75 | 15.52 |
| 毒品(滥用药物)检测(%) | - | 11.97 | 10.75 | 5.06 | - |
| 妊娠及优生优育检测(%) | - | 0.00 | - | 3.56 | - |
| 其他类(%) | - | 0.00 | - | 3.30 | - |